Celltrion
068270.KS
#679
Rank
HK$283.30 B
Marketcap
HK$1,242
Share price
-0.47%
Change (1 day)
33.82%
Change (1 year)
Celltrion is a Korean pharmaceutical company headquartered in Incheon, South Korea. Celltrion Healthcare conducts worldwide marketing, sales, and distribution of biological medicines developed by Celltrion.

EPS for Celltrion (068270.KS)

EPS in 2023 (TTM): HK$23.44

According to Celltrion 's latest financial reports the company's current EPS (TTM) is HK$25.53. In 2022 the company made an earnings per share (EPS) of HK$22.82 a decrease over its 2021 EPS that were of HK$27.12.

EPS history for Celltrion from 2007 to 2023

Annual EPS

Year EPS Change
2023 (TTM)HK$23.442.72%
2022HK$22.82-15.84%
2021HK$27.1212.77%
2020HK$24.0470.79%
2019HK$14.0815.63%
2018HK$12.18-33.13%
2017HK$18.21141.17%
2016HK$7.558.28%
2015HK$6.9711.28%
2014HK$6.2716.37%
2013HK$5.38-67.42%
2012HK$16.5384.22%
2011HK$8.9762.13%
2010HK$5.5380.61%
2009HK$3.06-559.63%
2008-HK$0.67-123.16%
2007HK$2.88